How to carry out growth assessment in infants and children under two years old

David Hopkins1, Alison Kyle1, Siba Prosad Paul2

  • 1Yeovil District Hospital, Yeovil, England.

Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|February 16, 2017
PubMed

Insights

Accurate infant growth monitoring requires precise measurement of weight, length, and head circumference. Correctly using equipment and charts is crucial for identifying faltering growth or malnutrition in children under two.

Area of Science:

  • Pediatrics
  • Clinical Assessment
  • Child Health Monitoring

Background:

  • Growth monitoring is vital for assessing the health of infants and young children.
  • Specific procedures and data are used for children under two years old.
  • Accurate growth assessment is essential in both hospital and community settings.

Purpose of the Study:

  • To outline the correct procedures for measuring infant and child growth.
  • To discuss key factors in growth assessment for children under two.
  • To emphasize the importance of accurate data collection and interpretation.

Main Methods:

  • Measuring and recording infant weight, length, and head circumference.
  • Utilizing appropriate growth measuring equipment and standardized growth charts.
  • Plotting and interpreting growth data to identify potential health issues.

Main Results:

  • Growth monitoring procedures for infants differ from those for older children.
  • Potential for errors exists in measuring, plotting, and interpreting growth data.
  • Accurate use of equipment and charts is essential for reliable results.

Conclusions:

  • Nurses must accurately measure and plot growth parameters (weight, length, head circumference).
  • Correct interpretation of growth data is key to identifying malnutrition and faltering growth.
  • Continuous professional development is necessary to maintain evidence-based practice in growth assessment.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
625
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.6K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
583
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405